Number of cycles A cycle is a defined treatment period with a protocol length that varies by peptide: CJC/Ipamorelin and Tesamorelin run 12-week (3-month) cycles, the Wolverine Stack (BPC-157/TB-500) runs on a 3-months-on, 2-months-off schedule, and GHK-Cu runs 30-day cycles
We are modifying the proposed definitions of median allowed amount, 10th percentile allowed amount, and 90th percentile allowed amount at 180.20 to replace the phrase, no longer than 12 months with no less than 12 months and no longer than 15 months, thus requiring hospitals to use a lookback period of no less than 12 months and no longer than 15 months prior to posting the MRF
Riesenberg D
The advisory committee's vote suggests that the data supports a favorable risk-benefit profile, but caution remains necessary
(PubMed) Weir DG, Scott JM
C.CorteseI.BlakeA.OhayonJ.CherupJ.et al